Predictive factors for prolonged sick leave in breast cancer patients treated with adjuvant therapies: a retrospective registry study

References

• “WHO | Breast cancer, prevention and control,” WHO. [cited 2018 Oct 5]. Available from: http://www.who.int/cancer/detection/breastcancer/en/.
   Google Scholar
• Global Burden of Disease Study 2015 (GBD 2015). Results United States, Institute for Health Metrics and Evaluation (IHME). [cited 2017 Jan 7]. http://ghdx.healthdata.org/gbd-results-tool. 2016.
   Google Scholar
• Hauglann B, Benth JŠ, Fosså SD, et al. A cohort study of permanently reduced work ability in breast cancer patients. J Cancer Surviv. 2012;6(3):345–356. doi: 10.1007/s11764-012-0215-0.
   PubMed Web of Science ®Google Scholar
• Blinder VS, Murphy MM, Vahdat LT, et al. Employment after a breast cancer diagnosis, a qualitative study of ethnically diverse urban women. J Community Health. 2012;37(4):763–772. doi: 10.1007/s10900-011-9509-9.
   PubMed Web of Science ®Google Scholar
• Mackenzie CR. ‘It is hard for mums to put themselves first’, how mothers diagnosed with breast cancer manage the sociological boundaries between paid work, family and caring for the self. Soc Sci Med. 2014;117:96–106. doi: 10.1016/j.socscimed.2014.07.043.
   PubMed Web of Science ®Google Scholar
• Kennedy F, Haslam C, Munir F, et al. Returning to work following cancer, a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl). 2007;16(1):17–25. doi: 10.1111/j.1365-2354.2007.00729.x.
   PubMed Web of Science ®Google Scholar
• Peteet JR. Cancer and the meaning of work. Gen Hosp Psychiatry. 2000; 22(3):200–205. doi: 10.1016/s0163-8343(00)00076-1.
   PubMed Web of Science ®Google Scholar
• Rasmussen DM, Elverdam B. The meaning of work and working life after cancer, an interview study. Psychooncology. 2008; 17(12):1232–1238. doi: 10.1002/pon.1354.
   PubMed Web of Science ®Google Scholar
• Arfi A, Baffert S, Soilly AL, et al. Determinants of return at work of breast cancer patients, results from the OPTISOINS01 french prospective study. BMJ Open. 2018;8(5):e020276. doi: 10.1136/bmjopen-2017-020276.
   PubMed Web of Science ®Google Scholar
• De Boer AG, Verbeek JH, Spelten ER, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–1347. doi: 10.1038/sj.bjc.6604302.
   PubMed Web of Science ®Google Scholar
• Drolet M, Maunsell E, Mondor M, et al. Work absence after breast cancer diagnosis, a population-based study. CMAJ. 2005;173(7):765–771. doi: 10.1503/cmaj.050178.
   PubMed Web of Science ®Google Scholar
• De Boer AG, Taskila T, Ojajärvi A, et al. Cancer survivors and unemployment, a meta-analysis and meta-regression. Jama. 2009;301(7):753–762. doi: 10.1001/jama.2009.187.
   PubMed Web of Science ®Google Scholar
• Carlsen K, Oksbjerg Dalton S, Frederiksen K, et al. Cancer and the risk for taking early retirement pension, a danish cohort study. Scand J Public Health. 2008;36(2):117–125. doi: 10.1177/1403494807085192.
   PubMed Web of Science ®Google Scholar
• Balak F, Roelen CA, Koopmans PC, et al. Return to work after early-stage breast cancer, a cohort study into the effects of treatment and cancer-related symptoms. J Occup Rehabil. 2008;18(3):267–272. doi: 10.1007/s10926-008-9146-z.
   PubMed Web of Science ®Google Scholar
• Islam T, Dahlui M, Majid HA, et al. Factors associated with return to work of breast cancer survivors, a systematic review. BMC Public Health. 2014;14(Suppl 3):S8. doi: 10.1186/1471-2458-14-S3-S8.
   PubMed Web of Science ®Google Scholar
• Roelen CA, Koopmans PC, De Graaf JH, et al. Sickness absence and return to work rates in women with breast cancer. Int Arch Occup Environ Health. 2009;82(4):543–546. doi: 10.1007/s00420-008-0359-4.
   PubMed Web of Science ®Google Scholar
• Torkki P, Leskelä RL, Linna M, et al. Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014. Acta Oncol. 2018;57(7):983–988. doi: 10.1080/0284186X.2018.1438656.
   PubMed Web of Science ®Google Scholar
• Won KA, Spruck C. Triple‑negative breast cancer therapy, current and future perspectives. Int J Oncol. 2020;57(6):1245–1261. doi: 10.3892/ijo.2020.5135.
   PubMed Web of Science ®Google Scholar
• Lidgren M, Wilking N, Jönsson B. Cost of breast cancer in Sweden in 2002. Eur J Health Econ. 2007;8(1):5–15. doi: 10.1007/s10198-006-0003-8.
   PubMed Web of Science ®Google Scholar